Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolvaptan for hyponatremia and ascites in liver cirrhosis
KCT0000569Phase 4Recruiting
- Sponsor
- Korea Otsuka Pharmaceutical
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tolvaptan in Cirrhosis, ascites, hyponatraemia, sponsored by Korea Otsuka Pharmaceutical. Started Dec 2012; status: recruiting.
02
Drugs
tolvaptan
03
Conditions
Cirrhosisasciteshyponatraemia
Beyond the preview
Go deeper on KCT0000569.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0000569.